Prism Medico & Pharmacy Hits 52-Week Low, Underperforms Sector and Market
Prism Medico & Pharmacy, a microcap healthcare services company, has been on a downward trend for the past three days, with a decrease of -12.71% in returns. On March 26, the stock hit a 52-week low of Rs 22.05, showing high volatility and trading below its moving averages. With a negative performance of -19.26% in the past year, investors may want to consider selling their shares in the company.
Prism Medico & Pharmacy, a microcap healthcare services company, has recently hit a 52-week low on March 26, 2024. The stock has been underperforming the sector by -11.93% and has been on a downward trend for the past three days, with a decrease of -12.71% in returns during this period.
On March 26, the stock touched an intraday low of Rs 22.05, which is a significant decrease of -14.77%. The stock has also shown high volatility today, with an intraday volatility of 7.97%, calculated from the weighted average price.
Prism Medico & Pharmacy is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a bearish trend for the stock.
In the past year, Prism Medico & Pharmacy has shown a negative performance of -19.26%, while the Sensex has shown a positive performance of 25.98%. This further highlights the underperformance of the company's stock.
MarketsMOJO has given a 'Sell' call for Prism Medico & Pharmacy, suggesting that investors should consider selling their shares in the company. With the stock hitting a 52-week low and underperforming the sector and market, it may be a good time for investors to re-evaluate their investment in Prism Medico & Pharmacy.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
